BioCentury
ARTICLE | Finance

Hidden in the rough

Biotech winners, losers in 2Q18

June 30, 2018 3:05 AM UTC

Judicious stock picking was especially important in the second quarter, as 57% of global biotech stocks saw their equity values decline.

Volatility continued to roil global markets during the period and additional uncertainty looms with the U.S. mid-term elections on Nov. 6 expected to come into focus after the annual summer slowdown...